Internal Medicine · Van Wert, OH
NPI
1376535914
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
214 Towne Center Blvd
Van Wert, OH, 45891
Phone (419) 232-2077
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
641 services
Medicare patients, 2024
259
Average age 74
Drug cost, 2024
$3.0M
30,248 prescriptions
Company payments, 2025
$894
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Kalogerou was code 90480 (vaccine administration), 119 times for 112 patients. In total Paul A Kalogerou billed 641 services in 29 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90480 Vaccine Administration | Office | 119 | 112 | $39.20 | $4,665 |
| 91320 Vaccine Product | Office | 117 | 110 | $148.63 | $17K |
| 99349 Home E&M - New and Established | Office | 96 | 56 | $56.13 | $5,389 |
| G0008 Administration of influenza virus vaccine | Office | 77 | 76 | $23.52 | $1,811 |
| 90662 Vaccine Product | Office | 73 | 72 | $81.68 | $5,963 |
| 99309 SNF E&M | Facility | 36 | 26 | $63.59 | $2,289 |
| 99406 Behavioral Health Services | Office | 26 | 22 | $13.68 | $356 |
| 99306 SNF E&M | Facility | 25 | 25 | $114.32 | $2,858 |
By year: 2022 $139K for 3,726 services; 2023 $140K for 6,635 services; 2024 $47K for 641 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Kalogerou prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,478 prescriptions and refills. In total Paul A Kalogerou wrote 30,248 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,478 | 2,308 | 252 | $14K |
| Levothyroxine Sodium Generic | 1,364 | 2,289 | 217 | $14K |
| Pantoprazole Sodium Generic | 1,000 | 1,523 | 206 | $13K |
| Amlodipine Besylate Generic | 733 | 1,309 | 146 | $3,935 |
| Furosemide Generic | 598 | 812 | 119 | $3,224 |
| Potassium Chloride Generic | 583 | 783 | 111 | $17K |
| Metoprolol Succinate Generic | 577 | 921 | 108 | $8,898 |
| Eliquis Apixaban | 576 | 682 | 70 | $261K |
| Lisinopril Generic | 564 | 941 | 102 | $3,370 |
| Metformin Hcl Generic | 522 | 907 | 97 | $3,594 |
| Metoprolol Tartrate Generic | 487 | 653 | 96 | $3,053 |
| Trazodone Hcl Generic | 449 | 622 | 79 | $3,524 |
| Gabapentin Generic | 426 | 497 | 74 | $5,864 |
| Divalproex Sodium Generic | 404 | 465 | 52 | $20K |
| Omeprazole Generic | 391 | 676 | 79 | $3,799 |
Brand drugs: 4,181 claims; generic drugs: 25,732 claims; opioid claims: 216.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Kalogerou $894 ($894 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $163.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $163 |
| Abbvie Inc. ABBV | 9 | $150 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $72.44 |
| Lilly USA, LLC LLY | 3 | $56.17 |
| Abbott Laboratories ABT | 2 | $54.48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $51.04 |
| Aimmune Therapeutics, Inc. | 3 | $49.08 |
| Novo Nordisk Inc NVO | 3 | $47.09 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $33.92 |
| Exact Sciences Corporation EXAS | 2 | $32.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.